Acceder Registro /

FELIPE DE ARRIBA DE LA FUENTE

Buscador

Hernández-Espinosa D, Miñano A, Martínez C, Ordoñez A, Pérez-Ceballos E, de Arriba F, Mota RA, Ferrer F, González M, Vicente V, Corral J. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin. Lab Invest. 2008 Mar;88(3):306-17. doi: 10.1038/labinvest.3700717. Epub 2008 Jan 14. PubMed PMID: 18195690.
AÑO: 2008; IF: 4.58
Mateos MV, Hernández JM, Hernández MT, Gutiérrez NC, Palomera L, Fuertes M, Garcia-Sanchez P, Lahuerta JJ, de la Rubia J, Terol MJ, Sureda A, Bargay J, Ribas P, Alegre A, de Arriba F, Oriol A, Carrera D, García-Laraña J, García-Sanz R, Bladé J, Prósper F, Mateo G, Esseltine DL, van de Velde H, San Miguel JF. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression. Haematologica. 2008 Apr;93(4):560-5. doi: 10.3324/haematol.12106. Epub 2008 Mar 5. PubMed PMID: 18322252.
AÑO: 2008; IF: 5.978
Fernández A, De Arriba F, Rivera J, Heras I, Vicente V, Lozano ML. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies. Haematologica. 2008 Sep;93(9):1436-8. doi: 10.3324/haematol.13056. Epub 2008 Jul 18. PubMed PMID: 18641021.
AÑO: 2008; IF: 5.978
Jerez A, Ortuño FJ, Osma Mdel M, Español I, González AD, Roldán V, de Arriba F, Vicente V. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance. Ann Med. 2009;41(7):547-58. doi: 10.1080/07853890903111000. PubMed PMID: 19634064.
AÑO: 2009; IF: 4.246
Blanquer M, Cava C, Ruiz FM, Cascales A, Cascales A, de Arriba F, Moraleda JM, Vicente V. Massive intestinal infiltration in a patient with bone T-cell rich diffuse large B cell lymphoma. Haematologica. 2003 May;88(5):EIM05. PubMed PMID: 12745289.
AÑO: 2003; IF: 3.453

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R